Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hospitals kick orthopedic sales reps out of the OR
Mass Device
Tuesday, September 9, 2014 - 10:45am
tags:
devices, hospitals, Orthopedics
BD: We'll make half our products in Asia by 2024
Mass Device
Tuesday, September 9, 2014 - 10:43am
tags:
Becton Dickinson, devices, Asia
GSK and Gilead’s combination therapy: positive results in PAH
Pharmaphorum
Tuesday, September 9, 2014 - 10:36am
tags:
GSK, Gilead Sciences, PAH, pulmonary arterial hypertension, Letairis, Adcirca
Who's Winning The Insulin Showdown?
Bidness Etc.
Tuesday, September 9, 2014 - 10:33am
tags:
insulin, diabetes, Eli Lilly, Sanofi, Lantus, Peglispro
IPO Filing: PRA Health Sciences
24/7 Wall St
Tuesday, September 9, 2014 - 10:32am
tags:
IPOs, CROs, PRA Health Sciences
Sanofi's Menactra Gets FDA Approval As Booster Vaccine
Bidness Etc.
Tuesday, September 9, 2014 - 10:28am
tags:
Sanofi, Menactra, FDA, vaccines, meningococcal disease
Boehringer's next-gen COPD treatment hits the mark in Phase III
Fierce Biotech
Tuesday, September 9, 2014 - 10:26am
tags:
Boehringer Ingelheim, COPD, Striverdi, Spiriva
GSK Facing Multimillion Dollar Settlement Or Fines Because Of US Probe
Bidness Etc.
Tuesday, September 9, 2014 - 10:20am
tags:
GSK, bribery
MHRA and Novartis lead consortium to develop adverse drug reaction app
In-Pharma Technologist
Tuesday, September 9, 2014 - 10:18am
tags:
Novartis, MHRA, mobile apps, adverse events
Two Promising Gene Therapy Stocks Tackling Eye Disease
TheStreet.com
Tuesday, September 9, 2014 - 10:15am
tags:
Applied Genetic Technologies, Avalanche Biotechnologies, eye disease
FDA staff: Novo Nordisk drug liraglutide effective for obesity
Yahoo/Reuters
Tuesday, September 9, 2014 - 10:03am
tags:
FDA, Novo Nordisk, liraglutide, obesity, Victoza
More Obesity Drugs Seek to Enter Still Struggling Market
Bloomberg
Tuesday, September 9, 2014 - 8:08am
tags:
obesity, Orexigen, Novo Nordisk, NB32, liraglutide, Victoza, Takeda
Bristol-Myers Needs a Healthy Growth Shot to Justify Its Valuation
TheStreet.com
Tuesday, September 9, 2014 - 8:05am
tags:
Bristol-Myers Squibb
Johnson & Johnson Should Ignore Those Breakup Calls
TheStreet.com
Tuesday, September 9, 2014 - 8:04am
tags:
JNJ
Single-Dose Flu Drug Shows Promise in Trials
Drug Discovery and Development
Monday, September 8, 2014 - 9:40pm
tags:
Biocryst, influenza, Rapivab
Can anything slow Gilead down? Analysts say no
CNBC
Monday, September 8, 2014 - 8:16pm
tags:
Gilead Sciences, Sovaldi, hepatitis C
AbbVie, Teva Sued by FTC Over Delay in Generic AndroGel
Bloomberg
Monday, September 8, 2014 - 8:15pm
tags:
AbbVie, Teva Pharmaceutical, FTC, generics, Androgel
Five Reason Amgen Won’t Be Breaking Up
Barron's
Monday, September 8, 2014 - 8:14pm
tags:
Amgen
Roche's RoACTEMRA To Go Up Against Anti-Rheumatoid Arthritis Drugs From Bristol-Myers, AbbVie
Bidness Etc.
Monday, September 8, 2014 - 12:29pm
tags:
Roche, rheumatoid arthritis, RoActemra, AbbVie, Bristol-Myers Squibb
Keytruda Cancer Drug Approval Is A Triumph For Merck: R&D Chief Roger Perlmutter On What's Next
Forbes
Monday, September 8, 2014 - 12:28pm
tags:
Merck, Keytruda, R&D, Roger Perlmutter

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.